Publications - Carterra

Press Release

Leerink Partners Report Names Carterra a Core Enabler of the $7B “Lab-in-the-Loop” Antibody Discovery Market

Press Release

William Blair Analysts Name Carterra a Winner in Life Science Tools for Enabling AI Drug Discovery at Unprecedented Scale

Publication • Peer-Reviewed Publication

William Blair: From Code to Clinic How AI Is (and Isn’t) Rewriting the Life of a Drug

Publication • Peer-Reviewed Publication

Cell Reports: Human Neutralizing Antibodies Targeting the Measles Virus Hemagglutinin and Fusion Surface Proteins

Publication • Peer-Reviewed Publication

Journal of Medicinal Chemistry: On-DNA Binder Confirmation: Increasing Confidence in DEL Hits

Pre-Print Publication

Better Antibodies Engineered with a GLIMPSE of Human Data

Peer-Reviewed Publication

Cell Reports: A Global Collaboration for Systematic Analysis of Broad-ranging Antibodies Against the SARS-CoV-2 Spike Protein

Book Chapter

Springer Nature: Epitope Mapping Protocols – Chapter 19: Competitive Epitope Binning Using HT-SPR

Peer-Reviewed Publication

Nature: Evolutionary Regulation of Human Fas Ligand (CD95L) by Plasmin in Solid Cancer Immunotherapy

Peer-Reviewed Publication

Science: Broadly neutralizing antibodies target the coronavirus fusion peptide

Peer-Reviewed Publication

Science: Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium study

Peer-Reviewed Publication

Science: Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern

Peer-Reviewed Publication

Nature: Multivalency Transforms SARS-CoV-2 Antibodies into Ultrapotent Neutralizers

Peer-Reviewed Publication

Nature Medicine: A candidate antibody drug for prevention of malaria

1
2